- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-10-0016533

Adiros Pharma Private Limited
About Adiros Pharma Private Limited
Data last updated:
Adiros Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 26 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2021PTC385644.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.02 Lakh. It is led by directors Anita Jha and Shashi Bala Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Shri Abhinav Jha Rzf – 773/34 Street No. – 13 Raj Nagar – 2 Near B – Block Dwarka Secto, R 8, New Delhi, Delhi, India – 110077.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.22 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹18,816 (net margin -0.3%) and EBITDA of -₹11,153 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 89% over three years.
Adiros Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0016533).
Company details
Recognitions & Rankings of Adiros Pharma
Contact details
Adiros Pharma Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressC/O – Shri Abhinav Jha Rzf – 773/34 Street No. – 13 Raj Nagar – 2 Near B – Block Dwarka Secto, R 8, New Delhi, Delhi, India – 110077
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adiros Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adiros Pharma Private Limited, buy the company report.
Financials of Adiros Pharma Private Limited
FY 2025 filings availableAdiros Pharma Private Limited reported revenue of ₹63.22 Lakh (up 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 89% over three years, including 39% growth in the latest year. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹11,153 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹18,816 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.2% | |||
| Net Profit Margin | -0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Adiros Pharma Private Limited, buy the company report.
Board of directors of Adiros Pharma Private Limited
Adiros Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Jha | Director | 26 Aug 2021 | 5 Years 1 Months | Current |
| Shashi Bala Jha | Director | 07 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Adiros Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pranvi Endeavours Private Limited | ₹63.25 Lakh (FY 2020) | 3433.0% | Indore, Madhya Pradesh, India | |||
| Anay Exports Private Limited | ₹63.25 Lakh (FY 2025) | 161.0% | Gurgaon, Haryana, India | |||
| Citizen Protective Services Private Limited | ₹63.24 Lakh (FY 2025) | 10.0% | Bangalore, Karnataka, India | |||
| JSS Springs Private Limited | ₹63.23 Lakh (FY 2024) | 119.0% | Indore, Madhya Pradesh, India | |||
| Lily Medical Stores Private Limited | ₹63.23 Lakh (FY 2023) | -64.0% | Kolkata, West Bengal, India | |||
| Adiros Pharma Private Limitedthis company | ₹63.22 Lakh (FY 2025) | -₹18,816 | -0.3% | 39.0% | New Delhi, Delhi, India | |
| Hi-Design Plylam Private Limited | ₹63.21 Lakh (FY 2020) | -31.0% | Hyderabad, Telangana, India | |||
| Makarim Attire Private Limited | ₹63.21 Lakh (FY 2020) | -3.0% | Kolkata, West Bengal, India | |||
| Nivasai Trade and Systems Private Limited | ₹63.21 Lakh (FY 2025) | -65.0% | Ranchi, Jharkhand, India | |||
| Sanative Bio-Science Private Limited | ₹63.21 Lakh (FY 2025) | 10.0% | Jaipur, Rajasthan, India | |||
| Mangal Papers Indore Limited | ₹63.21 Lakh (FY 2024) | -35.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Adiros Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adiros Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adiros Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Adiros Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Adiros Pharma Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Shashi Bala Jha ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Adiros Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in human health activities, within the healthcare industry. It was incorporated on 26 August 2021 (5+ years old) and is registered under CIN U85100DL2021PTC385644.
Adiros Pharma has 2 current directors:
- Anita Jha - Director
- Shashi Bala Jha - Director
The latest financial statements of Adiros Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Adiros Pharma is U85100DL2021PTC385644. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adiros Pharma was incorporated on 26 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Adiros Pharma by revenue are Pranvi Endeavours Private Limited, Anay Exports Private Limited, Citizen Protective Services Private Limited, JSS Springs Private Limited, Lily Medical Stores Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Shashi Bala Jha ceased to be Additional Director on 29 Sep 2023. Shashi Bala Jha was appointed as Director on 07 Mar 2022. Sushma Kumari ceased to be Director on 07 Mar 2022. Adiros Pharma has 4 board changes on record in total.
Yes, Adiros Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0016533).
The registered office of Adiros Pharma is at CO – Shri Abhinav Jha Rzf – 77334 Street No. – 13 Raj Nagar – 2 Near B – Block Dwarka Secto, R 8, New Delhi, Delhi, India – 110077.
Adiros Pharma operates in the healthcare industry, in the human health activities segment.
Adiros Pharma can be reached at its registered office: CO – Shri Abhinav Jha Rzf – 77334 Street No. – 13 Raj Nagar – 2 Near B – Block Dwarka Secto, R 8, New Delhi, Delhi, India – 110077.